Market Research Logo

Malaysia Pharmaceuticals and Healthcare Report Q2 2015

141 Pages BMI Research April 03, 2015 SKU: BMI5518730

BMI View: Commercial opportunities for private healthcare providers in Malaysia will be buoyed by therobust growth in the country's medical tourism industry. Driven by strong demand from Asia and theweakening currency, we highlight that this trend will also create revenue prospects for innovativepharmaceutical companies. However, the implementation of the Goods and Service Tax (GST) on April 1stposes a downside risk to our forecast as the government seeks to introduce price control measures on nonexempthigh value medicines.

Headline Expenditure Projections

Pharmaceuticals: MYR7.22bn (USD2.21bn) in 2014 to MYR7.88bn (USD2.24bn) in 2015; +9.2 % inlocal currency and +1.5% in US dollar terms.

Healthcare: MYR43.82bn (USD13.39bn) in 2014 to MYR47.64bn (USD13.53bn) in 2015; +8.7% inlocal currency and +1.1% in US dollar terms.

Show Full Description


Show Table of Contents



Malaysia Pharmaceuticals and Healthcare Report Q2 2015

BMI Research
April 03, 2015

Pricing & Delivery

Report with 3 quarterly updates
$1,295
Report with 3 quarterly updates - 3 User License
$1,945
Report with 3 quarterly updates - 5 User License
$2,500
Report with 3 quarterly updates - Departmental/Site License
$2,995
Global Site License Fulfilled by Publisher
$6,995

Didn't find what you are looking for?

Let us find it for you. One of our knowledgeable research assistants will work with you to find exactly the right research to answer your questions:

US: 800.298.5699 International: +1.240.747.3093 Or leave us a message and we'll call you back!

Receive bi-weekly email alerts for new market research.



CTA Image

Download our free eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.


Download CTA

Share this report